The global threat of counterfeit drugs: why industry and governments must communicate the dangers.

The global threat of counterfeit drugs: why industry and governments must communicate the dangers.

Bibliographic Details
Main Authors: Robert Cockburn, Paul N Newton, E Kyeremateng Agyarko, Dora Akunyili, Nicholas J White
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2005-04-01
Series:PLoS Medicine
Online Access:http://europepmc.org/articles/PMC1062889?pdf=render
id doaj-b42487f28b424bd99d643950ae16b074
record_format Article
spelling doaj-b42487f28b424bd99d643950ae16b0742020-11-25T01:53:40ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762005-04-0124e10010.1371/journal.pmed.0020100The global threat of counterfeit drugs: why industry and governments must communicate the dangers.Robert CockburnPaul N NewtonE Kyeremateng AgyarkoDora AkunyiliNicholas J Whitehttp://europepmc.org/articles/PMC1062889?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Robert Cockburn
Paul N Newton
E Kyeremateng Agyarko
Dora Akunyili
Nicholas J White
spellingShingle Robert Cockburn
Paul N Newton
E Kyeremateng Agyarko
Dora Akunyili
Nicholas J White
The global threat of counterfeit drugs: why industry and governments must communicate the dangers.
PLoS Medicine
author_facet Robert Cockburn
Paul N Newton
E Kyeremateng Agyarko
Dora Akunyili
Nicholas J White
author_sort Robert Cockburn
title The global threat of counterfeit drugs: why industry and governments must communicate the dangers.
title_short The global threat of counterfeit drugs: why industry and governments must communicate the dangers.
title_full The global threat of counterfeit drugs: why industry and governments must communicate the dangers.
title_fullStr The global threat of counterfeit drugs: why industry and governments must communicate the dangers.
title_full_unstemmed The global threat of counterfeit drugs: why industry and governments must communicate the dangers.
title_sort global threat of counterfeit drugs: why industry and governments must communicate the dangers.
publisher Public Library of Science (PLoS)
series PLoS Medicine
issn 1549-1277
1549-1676
publishDate 2005-04-01
url http://europepmc.org/articles/PMC1062889?pdf=render
work_keys_str_mv AT robertcockburn theglobalthreatofcounterfeitdrugswhyindustryandgovernmentsmustcommunicatethedangers
AT paulnnewton theglobalthreatofcounterfeitdrugswhyindustryandgovernmentsmustcommunicatethedangers
AT ekyerematengagyarko theglobalthreatofcounterfeitdrugswhyindustryandgovernmentsmustcommunicatethedangers
AT doraakunyili theglobalthreatofcounterfeitdrugswhyindustryandgovernmentsmustcommunicatethedangers
AT nicholasjwhite theglobalthreatofcounterfeitdrugswhyindustryandgovernmentsmustcommunicatethedangers
AT robertcockburn globalthreatofcounterfeitdrugswhyindustryandgovernmentsmustcommunicatethedangers
AT paulnnewton globalthreatofcounterfeitdrugswhyindustryandgovernmentsmustcommunicatethedangers
AT ekyerematengagyarko globalthreatofcounterfeitdrugswhyindustryandgovernmentsmustcommunicatethedangers
AT doraakunyili globalthreatofcounterfeitdrugswhyindustryandgovernmentsmustcommunicatethedangers
AT nicholasjwhite globalthreatofcounterfeitdrugswhyindustryandgovernmentsmustcommunicatethedangers
_version_ 1724989771453825024

Similar Items